Description: Chordate Medical Holding AB (publ), a medical technology company, engages in the development of products and solutions for the treatment of chronic migraine and rhinitis in Sweden. It offers Ozilia, a neuromodulation and drug-free treatment technology for chronic migraine and chronic rhinitis. The company was founded in 2005 and is based in Kista, Sweden.
Home Page: www.chordate.com
KistagAngen 20B
Kista,
164 40
Sweden
Phone:
46 8 40 01 15 86
Officers
| Name | Title |
|---|---|
| Mr. Anders Weilandt | CEO & MD |
| Mr. Niklas Lindecrantz | Chief Financial Officer |
| Mr. Jan Lindberg | CTO and Head of R&D, Production & Quality |
| Mr. Jan Hermansson | Chief Scientific Officer and Clinical Research & Medical Director |
| Ms. Helena Ossmer Thedius | Sales & Marketing Manager |
Exchange: ST
Country: SE : Sweden
Currency: Swedish krone (kr)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.0167 |
| Price-to-Sales TTM: | 5.0671 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 3 |